HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Animal Mammary Neoplasms

Subscribe to New Research on Animal Mammary Neoplasms

Tumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL).

Also Known As:

Mammary Neoplasms, Animal; Animal Mammary Carcinoma; Mammary Carcinoma, Animal; Mammary Neoplasms; Neoplasms, Mammary; Animal Mammary Carcinomas; Animal Mammary Neoplasm; Carcinoma, Animal Mammary; Carcinomas, Animal Mammary; Mammary Carcinomas, Animal; Mammary Neoplasm; Mammary Neoplasm, Animal; Neoplasm, Animal Mammary; Neoplasm, Mammary; Neoplasms, Animal Mammary

Networked: 59 relevant articles (0 outcomes, 8 trials/studies) for this Disease, Comments

Disease Context: Research Results

Related Diseases

1.	Neoplasms (Cancer)
2.	Breast Neoplasms (Breast Cancer)
3.	Neoplasm Metastasis (Metastasis)
4.	Infection
5.	Hyperplasia

Experts

1.	Roubies, N: 2 articles (09/2006 - 12/2003)
2.	Polizopoulou, Z S: 2 articles (09/2006 - 12/2003)
3.	Koutinas, A F: 2 articles (09/2006 - 12/2003)
4.	Karayannopoulou, M: 2 articles (09/2006 - 12/2003)
5.	Kaldrymidou, E: 2 articles (09/2006 - 12/2003)
6.	Fytianou, A: 2 articles (09/2006 - 12/2003)
7.	Siracusa, Carlo: 1 article (09/2009)
8.	Saco, Yolanda: 1 article (09/2009)
9.	Planellas, Marta: 1 article (09/2009)
10.	Pato, Raquel: 1 article (09/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Animal Mammary Neoplasms:

1.	HormonesIBA 01/01/2002 - "Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer." 07/01/1986 - "Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm." 11/18/1975 - "[In-vivo effect of prolactin-inhibiting substances on the amino-acid incorporation rate into hormone-depending mammary neoplasms of the rat]" 03/01/1986 - "As previous studies have suggested a hormone dependence of binding sites for peanut agglutinin in mammary neoplasm, this feature has been thought to be correlated to steroid receptor status. " 04/01/2000 - "The expression of hormone receptors and their relationship to cell proliferation in six samples of normal canine mammary tissue, and 11 benign and 10 malignant mammary neoplasms from female dogs were assessed by immunohistochemistry in formalin-fixed paraffin-embedded samples, by using monoclonal antibodies against progesterone and oestrogen receptors, and nuclear antigen Ki-67 (MIB-1). " Order ALL the reference details at left...
2.	Peanut AgglutininIBA 03/01/1986 - "As previous studies have suggested a hormone dependence of binding sites for peanut agglutinin in mammary neoplasm, this feature has been thought to be correlated to steroid receptor status. " Order ALL the reference details at left...
3.	ConnexinsIBA 09/01/2005 - "Mammary neoplasms represent the second most frequent neoplasm in dogs, and since there are no reports on the study of connexins in canine mammary glands, the present study investigated the expression of connexins 26 and 43 in normal, hyperplastic, and neoplastic mammary glands of this species, to verify if altered patterns of connexin staining are related to higher cell proliferation and malignant phenotypes. " 09/01/2005 - "In conclusion, the expression and distribution of connexins and E-cadherin are inversely correlated to cell proliferation in malignant mammary neoplasms of dogs and may well be related to their more aggressive histologic type and biologic behavior." Order ALL the reference details at left...
4.	Steroid Receptors (Steroid Receptor)IBA 03/01/1986 - "As previous studies have suggested a hormone dependence of binding sites for peanut agglutinin in mammary neoplasm, this feature has been thought to be correlated to steroid receptor status. " 03/01/1986 - "Binding of fluorescein isothiocyanate conjugated lectins to MXT mouse mammary neoplasm and their relation to steroid receptor status." Order ALL the reference details at left...
5.	Fibronectins (Fibronectin)IBA 11/01/1994 - "The aim of the study was to evaluate the possible changes in the alpha 5 beta 1 integrin receptor and its ligand fibronectin in relation to the metastatic capacity of canine mammary neoplasms. " 11/01/1994 - "Stromal fibronectin was increased in most cases and cytoplasmic staining of fibronectin was observed in epithelial and myoepithelial cells in mammary neoplasms but not in normal or dysplastic mammary tissue. " Order ALL the reference details at left...
6.	Contraceptive Agents (Contraceptives)IBA 08/01/1989 - "The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives is a large multinational hospital-based case-control study of steroid contraceptives and gynecologic, hepatobiliary, and mammary neoplasms. " Order ALL the reference details at left...
7.	CarcinogensIBA 08/01/1976 - "The induction by chemical carcinogens of intraductal hyperplasias in a relatively high incidence, with associated mammary neoplasms, provides a system for study of the process of tumor progression in lesions similar to suspected high-risk lesions occurring in human breast cancer." Order ALL the reference details at left...
8.	Differentiation AntigensIBA 01/01/2004 - "METHODS: Expression patterns for terminal differentiation markers were used to characterize tumor types and to study tumor progression in transgenic mouse models of mammary neoplasia (mice overexpressing Neu (Erbb2), Hras, Myc, Notch4, SV40-TAg, Tgfa, and Wnt1), in spontaneous mammary carcinomas, and in mammary neoplasms associated with infection by the mouse mammary tumor virus (MMTV). " 01/01/2004 - "Immunolabeling for terminal differentiation markers was compared among a variety of mouse mammary neoplasms because expression of terminal differentiation markers, and especially of keratins, provides important information on the origin of neoplastic cells and their degree of differentiation. " 01/01/2004 - "RESULTS: On the basis of the expression of terminal differentiation markers, three types of neoplasm were identified: first, simple carcinomas composed exclusively of cells with a luminal phenotype are characteristic of neoplasms arising in mice transgenic for Neu, Hras, Myc, Notch4, and SV40-TAg; second, 'complex carcinomas' displaying luminal and myoepithelial differentiation are characteristic of type P tumors arising in mice transgenic for Wnt1, neoplasms arising in mice infected by the MMTV, and spontaneous adenosquamous carcinomas; and third, 'carcinomas with epithelial to mesenchymal transition (EMT)' are a characteristic feature of tumor progression in Hras-, Myc-, and SV40-TAg-induced mammary neoplasms and PL/J and SJL/J mouse strains, and display de novo expression of myoepithelial and mesenchymal cell markers. " Order ALL the reference details at left...
9.	tebufenozide (Mimic)IBA 09/20/2005 - "Metastases to the breast are unusual lesions that make up approximately 2% of all malignant mammary neoplasms and may mimic both benign and malignant primary neoplasms from a clinical point of view, as well as in imaging studies. " Order ALL the reference details at left...
10.	9,10-Dimethyl-1,2-benzanthracene (DMBA)IBA 01/01/1971 - "[Development of DMBA-induced mammary neoplasms in rats with varying reactivity of the pituitary-ovary system]" 09/01/1987 - "Since no interactions were found for the usual measure of carcinogenesis, namely, incidence of rats with 1 or more neoplasms, the overall conclusion is that DMBA, PCZ, and x-ray act additively in the induction of mammary neoplasms in the female Sprague-Dawley rat." 05/01/1985 - "All carcinogen-treated rats exposed to FNT, MNU, or DMBA developed one or more ovarian, uterine, or mammary neoplasms with a total of 31 tumors in 22 rats as compared with no tumors in 5 control rats. " 09/01/1987 - "An exception to this finding of additivity was an apparent synergistic interaction between DMBA and PCZ when the measures of rats with 2 or more, or 3 or more mammary neoplasms of either type, or 3 or more fibroadenomas were analyzed; these analyses, however, were based on relatively small numbers of rats with multiple tumors. " 01/01/1986 - "[Estradiol and progesterone receptors in DMBA-induced mammary neoplasms in rats under cyclic hormonal exposures]" Order ALL the reference details at left...

Therapies and Procedures

1.	Intraperitoneal Injections 02/01/1975 - "In this study C3H/HeJ female mice received an intraperitoneal injection of mammary tumor suspended in saline; After 14 days, the presence of mammary neoplasm was detected by a significant change in the cytodifferential counts of aspirated peritoneal fluid. " Order ALL the reference details at left...
2.	Radiotherapy 08/01/1978 - "[Spontaneous mouse mammary neoplasm as a model for experimental radiotherapy]" 11/01/1966 - "[Post-irradiation osseous lesions in patients exposed to radiotherapy for mammary neoplasms]" 10/01/1955 - "[Histochemical variations in the connective tissue of mammary neoplasms after radiotherapy. " Order ALL the reference details at left...
3.	Transplants (Transplant) 12/15/1957 - "[The use of dermo-epidermal grafts as supplement to radical surgery of mammary neoplasms.]" Order ALL the reference details at left...
4.	X-Ray Therapy 03/01/1954 - "[Histochemical variations of the connective tissue of mammary neoplasms after roentgenotherapy.]" Order ALL the reference details at left...
5.	Transplantation (Transplant Recipients) 11/01/1991 - "Removal of an endogenous EGF stimulus by surgical ablation of the submaxillary glands, the major EGF-producing organ in mice, produced significantly slower growth of rodent mammary neoplasms, decreased success rate of transplantation, and an increase in the latent period before growth occurred. " Order ALL the reference details at left...

blog comments powered by Disqus

TREATMENT OPTIONS
for Animal Mammary Neoplasms,
Ranking and Evidence

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 0 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>